Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Director | May 23, 2023 | May 25, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date May 23, 2023 · Filed May 25, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,514 |
Reported balance
After 2023-05-24 transaction · row 1
1 source rowRow 1 · 2023-05-24 · Exercise / conversion · Acquired 6,465 · Balance 40,514 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,547 |
Reported balance
After 2023-05-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-05-23 · Grant · Acquired 28,547 · Balance 28,547 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-24 · Exercise / conversion · Disposed 6,465 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3: The RSUs vested in full on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.
F3: The RSUs vested in full on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2023 Filed May 25, 2023 17:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 6,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032214 · doc4.xml · derivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,465 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F3 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| May 24, 2023 Filed May 25, 2023 17:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-032214 · doc4.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| May 23, 2023 Filed May 25, 2023 17:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 28,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032214 · doc4.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,547 Underlying: Common Stock · 28,547 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| May 24, 2022 Filed May 24, 2022 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 6,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000069 · wf-form4_165343978397921.xml · derivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,465 Underlying: Common Stock · 6,465 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| May 21, 2022 Filed May 24, 2022 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,701 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000069 · wf-form4_165343978397921.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000069 · wf-form4_165343978397921.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000119 · wf-form4_162276677107310.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 2,023 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-21-000119 · wf-form4_162276677107310.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| May 21, 2021 Filed May 27, 2021 18:56 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000103 · wf-form4_162215617315187.xml · derivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 1,701 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,750 | $0.00 Strike: $50.04 | $0.00 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · derivative · entry 8 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 23,750 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,700 | $113.60 | $193,120.00 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 7 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,325 F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $113.19 to $114.17, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,152 | $112.46 | $129,553.92 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 6 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,025 F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $112.16 to $113.11, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 14,550 | $112.11 | $1,631,200.50 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 5 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,177 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $111.40 to $112.1295, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 700 | $111.01 | $77,707.00 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 4 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,727 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $110.38 to $111.35, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 848 | $109.49 | $92,847.52 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,427 F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $109.30 to $109.78, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,800 | $108.82 | $522,336.00 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,275 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $108.295 to $109.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 23,750 | $50.04 | $1,188,450.00 |
DisclosureSEC source: 0001666071-20-000287 · wf-form4_160556325668886.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 17:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 6,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000202 · wf-form4_159320544591273.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 17:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000202 · wf-form4_159320544591273.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 18:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000175 · wf-form4_159130938344351.xml · derivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,023 Underlying: Common Stock · 2,023 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · derivative · entry 7 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 182 | $70.56 | $12,842.10 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · nonDerivative · entry 5 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,818 | $70.56 | $339,958.56 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · nonDerivative · entry 4 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,154 Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · nonDerivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · derivative · entry 6 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,000 | $66.16 | $330,800.00 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · nonDerivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 16:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001666071-20-000160 · wf-form4_159112869229014.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · derivative · entry 6 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 28, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,000 | $65.01 | $325,050.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · nonDerivative · entry 4 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.111, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 28, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · nonDerivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · derivative · entry 5 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 27, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,000 | $64.38 | $321,900.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · nonDerivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 Read SEC document |
| May 27, 2020 Filed May 28, 2020 16:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001666071-20-000155 · wf-form4_159069777719458.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2020 Filed Apr 6, 2020 19:05 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 5,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000093 · wf-form4_158621433116012.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| April 04, 2020 Filed Apr 6, 2020 19:05 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 5,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000093 · wf-form4_158621433116012.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,750 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000174 · wf-form4_157541518565090.xml · derivative · entry 5 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 23,750 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 8,950 | $59.57 | $533,151.50 |
DisclosureSEC source: 0001666071-19-000174 · wf-form4_157541518565090.xml · nonDerivative · entry 4 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,020 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $59.23 to $60, inclusive. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 7,300 | $58.87 | $429,751.00 |
DisclosureSEC source: 0001666071-19-000174 · wf-form4_157541518565090.xml · nonDerivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,970 F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.22 to $59.20, inclusive. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 7,500 | $57.66 | $432,450.00 |
DisclosureSEC source: 0001666071-19-000174 · wf-form4_157541518565090.xml · nonDerivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,270 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $57.22 to $58.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 23,750 | $20.00 | $475,000.00 |
DisclosureSEC source: 0001666071-19-000174 · wf-form4_157541518565090.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 17:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 6,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-039144 · doc4.xml · derivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,353 Underlying: Common Stock · 6,353 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 17:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 5,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024016 · doc4.xml · derivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,952 Underlying: Common Stock · 5,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| March 09, 2019 Filed Apr 8, 2019 17:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 8,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024016 · doc4.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| March 09, 2019 Filed Apr 8, 2019 17:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-024016 · doc4.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionWarrant (Right to Buy) · Derivative | 6,636 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046110 · doc4.xml · derivative · entry 3 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,636 shares Expires 2023-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,636 | $0.00 | $2.65 |
DisclosureSEC source: 0001209191-18-046110 · doc4.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 21:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantWarrant (Right to Buy) · Derivative | 6,636 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046110 · doc4.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,636 Underlying: Common Stock · 6,636 shares Expires 2023-08-07 F2 · kind: The warrants were acquired pursuant to an agreement between the Reporting Person and the Issuer, dated May 4, 2017. The number of shares to be acquired (if any) upon exercise of the warrants could only be determined 180 days following the date of the Issuer's final prospectus relating to its initial public offering. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 16:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 8,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019230 · doc4.xml · derivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,484 Underlying: Common Stock · 8,484 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The restricted stock units shall vest in full on the one-year anniversary of date of grant, provided that the Reporting Person (i) has served as a director for at least six months and (ii) remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest in full on the one-year anniversary of date of grant, provided that the Reporting Person (i) has served as a director for at least six months and (ii) remains a director of the Issuer on such vesting date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 16:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G Redeemable Convertible Preferred Stock · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010367 · doc4.xml · derivative · entry 2 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 16:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionCommon Stock | 2,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-010367 · doc4.xml · nonDerivative · entry 1 Adams David Leslie · CIK 0001730500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series G Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.